Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 36, 2631-2635, July 1, 1976]
© 1976 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boutwell, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boutwell, R. K.

The Biochemistry of Preneoplasia in Mouse Skin1

R. K. Boutwell

McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin 53706

After an introduction to the "Session on Skin" emphasizing that some early biochemical changes occurring in the two-stage model system for skin would be presented in the three following presentations, several background experiments were discussed.

It was shown that a complete carcinogen for the skin (7,12-dimethylbenz[a]anthracene) provides both initiating and promoting components, but as the dose level of the carcinogen is lowered its promoting activity is lost while its initiating activity is retained. At the dose level that is completely carcinogenic, 7,12-dimethylbenz[a]anthracene exhibits the properties of a promoter; it stimulates RNA, protein, and DNA synthesis followed by cell division. At initiating doses, both the biochemical and morphological (increased mitosis) responses to treatment that are characteristic of promoters are lost; the remaining biochemical effects involve DNA and are attributed to initiating action.

Some of the data supporting the concept that the mechanism of action of tumor promotion involves gene activation were reviewed.

1 Presented at the Conference "Early Lesions and the Development of Epithelial Cancer," October 21 to 23, 1975. Bethesda, Md. This work was supported in part by grants from the American Cancer Society (BC-14) and from NIH (CA-07175 and CA-05002).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1976 by the American Association for Cancer Research.